nonachlazine has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lizogub, VG; Piatak, OA; Yanovskii, GV | 1 |
| Kozlov, VV; Lizogub, VG; Piatak, OA | 1 |
1 trial(s) available for nonachlazine and Coronary Artery Disease
| Article | Year |
|---|---|
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Levodopa; Middle Aged; Nonachlazine; Oxprenolol; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1991 |
1 other study(ies) available for nonachlazine and Coronary Artery Disease
| Article | Year |
|---|---|
[Cardiohemodynamics and microcirculation in patients with ischemic heart disease undergoing beta-adrenergic receptor stimulation and blockade].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Conjunctiva; Coronary Artery Disease; Drug Evaluation; Exercise Test; Heart; Hemodynamics; Humans; Microcirculation; Nonachlazine; Propranolol | 1990 |